Evidence map›Paper›PMID 28928635›Full record

ArticleFrontiers in cellular neuroscience2017

d-Tubocurarine and Berbamine: Alkaloids That Are Permeant Blockers of the Hair Cell's Mechano-Electrical Transducer Channel and Protect from Aminoglycoside Toxicity.

Nerissa K Kirkwood, Molly O'Reilly, Marco Derudas, Emma J Kenyon, Rosemary Huckvale, Sietse M van Netten, Simon E Ward, Guy P Richardson, Corné J Kros

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Identifying targets to prevent aminoglycoside ototoxicity.Molecular and cellular neurosciences · 2022
    Review
  16. Article
  17. AnFrontiers in molecular neuroscience · 2022
    Article
  18. Article
  19. The Use of Nanoparticles in Otoprotection.Frontiers in neurology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Nerissa K KirkwoodSussex Neuroscience, School of Life Sciences, University of SussexBrighton, United Kingdom.
Molly O'ReillySussex Neuroscience, School of Life Sciences, University of SussexBrighton, United Kingdom.
Marco DerudasSussex Drug Discovery Centre, School of Life Sciences, University of SussexBrighton, United Kingdom.
Emma J KenyonSussex Neuroscience, School of Life Sciences, University of SussexBrighton, United Kingdom.
Rosemary HuckvaleSussex Drug Discovery Centre, School of Life Sciences, University of SussexBrighton, United Kingdom.
Sietse M van NettenInstitute of Artificial Intelligence and Cognitive Engineering, University of GroningenGroningen, Netherlands.
Simon E WardSussex Drug Discovery Centre, School of Life Sciences, University of SussexBrighton, United Kingdom.
Guy P RichardsonSussex Neuroscience, School of Life Sciences, University of SussexBrighton, United Kingdom.
Corné J KrosSussex Neuroscience, School of Life Sciences, University of SussexBrighton, United Kingdom.
University of Sussex · GBUniversity of Groningen · NL

Funding

Medical Research Council MR/K005561/1
6 · The paper itself

Abstract

Aminoglycoside antibiotics are widely used for the treatment of life-threatening bacterial infections, but cause permanent hearing loss in a substantial proportion of treated patients. The sensory hair cells of the inner ear are damaged following entry of these antibiotics via the mechano-electrical transducer (MET) channels located at the tips of the hair cell's stereocilia. d-Tubocurarine (dTC) is a MET channel blocker that reduces the loading of gentamicin-Texas Red (GTTR) into rat cochlear hair cells and protects them from gentamicin treatment. Berbamine is a structurally related alkaloid that reduces GTTR labeling of zebrafish lateral-line hair cells and protects them from aminoglycoside-induced cell death. Both compounds are thought to reduce aminoglycoside entry into hair cells through the MET channels. Here we show that dTC (≥6.25 μM) or berbamine (≥1.55 μM) protect zebrafish hair cells

Indexed as

aminoglycosidesberbamined-tubocurarinehair cellhearing lossmechanotransductionototoxicity

Identifiers

PMID28928635
PMCPMC5591855
OpenAlexW2751142656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.